Alana Klein
partner, Duane Morris LLP
Alan Klein is a partner at Duane Morris LLP in Philadelphia, concentrates his practice in litigation and handles a wide variety of cases with a focus in recent years on products liability and toxic torts. He has served as national, regional and local counsel for Fortune 500 companies and other clients in class action antitrust, securities litigation and complex commercial cases.
|
Articles |
 |
|
Pharmaceutical Executive's Ad Stars
April 1, 2006
By:
Alana Klein
In 2005, healthcare advertising hit a new level of refinement in strategy and sophistication in execution. Even better, it reached a new place, where promotion and education sit comfortably together. Brand teams are growing and learning, particularly about using emotion to inspire action.
|
|
Alternative Media: Masters of Their Domain
March 1, 2006
By:
Alana Klein
For years, educational institutions have enjoyed their own Internet domain: .edu. US governmental agencies have .gov, and non-profits have been able to set themselves apart from the crowd with .org in their e-mail and Web addresses. Thanks to changes made to the Internet's Domain Name System (DNS) in 2001, subject-specific vertical segments have been able to flee the .com world for newly established domains, such as .travel, .jobs, .museum, and .info.
|
|
Direct to Consumer: Q&A with Jill Balderson
March 1, 2006
By:
Alana Klein
We need to do more than just distribute information—we need to look at how consumers process, internalize, and act on that information. Health education is a process that is very personal and complex.
|
|
Thought Leader: A Q&A with Graham Allaway
December 1, 2005
By:
Alana Klein
Some people are infected by HIV strains that are already resistant to FDA-approved drugs because they were transmitted by someone who developed resistance while receiving antiretroviral therapy. As a result, these patients often fail therapy.
|
|
Ad Agencies to the Rescue
October 1, 2005
By:
Alana Klein
The client-agency relationship is a product of its environment. Chock-full of regulatory requirements, scandals, and heightened FDA scrutiny, the current environment leaves much to be desired. But this is hardly news for the pharma industry.
|
Medical Education: Preferred Providers
August 1, 2005
By:
Alana Klein
CME providers that are affiliated with a university medical school or medical society are likely to obtain physicians' support for their programs, according to a survey conducted by Rogers Medical Intelligence Solutions, an accredited provider of CME. The survey, which examined physicians' CME provider preferences, found that many physicians prefer programs that are affiliated with respected university medical schools or medical societies over hospital-run programs or those self-accredited by medical communications agencies.
|
|